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Abstract
Many patients with primary brain tumors experience cognitive deficits. Cognitive rehabilitation programs focus on alleviating 
these deficits, but availability of such programs is limited. Our large randomized controlled trial (RCT) demonstrated posi-
tive effects of the cognitive rehabilitation program developed by our group. We converted the program into the iPad-based 
cognitive rehabilitation program ReMind, to increase its accessibility. The app incorporates psychoeducation, strategy training 
and retraining. This pilot study in patients with primary brain tumors evaluates the feasibility of the use of the ReMind-app 
in a clinical (research) setting in terms of accrual, attrition, adherence and patient satisfaction. The intervention commenced 
3 months after resective surgery and patients were advised to spend 3 h per week on the program for 10 weeks. Of 28 eligible 
patients, 15 patients with presumed low-grade glioma or meningioma provided informed consent. Most important reason 
for decline was that patients (7) experienced no cognitive complaints. Participants completed on average 71% of the strategy 
training and 76% of the retraining. Some patients evaluated the retraining as too easy. Overall, 85% of the patients evaluated 
the intervention as “good” or “excellent”. All patients indicated that they would recommend the program to other patients 
with brain tumors. The ReMind-app is the first evidence-based cognitive telerehabilitation program for adult patients with 
brain tumors and this pilot study suggests that postoperative cognitive rehabilitation via this app is feasible. Based on patients’ 
feedback, we have expanded the retraining with more difficult exercises. We will evaluate the efficacy of ReMind in an RCT.
Keywords Cognitive rehabilitation · Telerehabilitation · eHealth · Glioma · Meningioma · Neurosurgery
Introduction
Many patients with primary brain tumors suffer from cog-
nitive deficits [1, 2]. These deficits can cause difficulties in 
patients’ everyday lives and affect their quality of life [3, 4]. 
Reported prevalence rates of cognitive deficits vary widely, 
which is partly due to the differences in used methods, but 
range between 19 and 90% [2, 5, 6]. Since survival rates are 
increasing [7, 8] and patients are living longer with possible 
cognitive deficits, management of cognitive deficits becomes 
an increasingly important part of total care in patients with 
primary brain tumors.
Unfortunately, treatment options for these cognitive defi-
cits are scarce. Over the last years, a few intervention studies 
have been conducted in brain tumor patients, which demon-
strated positive effects of cognitive rehabilitation [9–11]. 
Our randomized controlled trial (RCT) in 140 glioma 
patients with stable disease demonstrated positive effects of 
a 6-week face-to-face cognitive rehabilitation program that 
consisted of psychoeducation, teaching of use of compensa-
tory skills and retraining [9, 12]. Despite the positive find-
ings of previous studies and patients’ needs for rehabilitation 
services, cognitive rehabilitation is not always accessible for 
every patient in clinical practice [13, 14]. Conventional in-
person cognitive rehabilitation can be demanding and costly, 
due to, amongst others, multiple hospital visits and lengthy 
face-to-face sessions with professionals.
To overcome some of the limitations of conventional 
cognitive rehabilitation, a number of studies explored the 
possibilities of cognitive telerehabilitation programs in other 
neurological and oncological patient populations [15–18]. 
Cognitive telerehabilitation is a form of eHealth, and it 
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is defined as “the use of information and communication 
technologies to provide rehabilitation services to people 
remotely in their homes or other environments” [19]. To our 
knowledge, no studies on cognitive telerehabilitation have 
been conducted in adult patients with brain tumors.
Based on the positive findings of our previous RCT, and 
ongoing requests of doctors and patients to utilize the cogni-
tive rehabilitation program, we converted our program into 
an iPad-based cognitive rehabilitation application, named 
ReMind. The goal of the development of the ReMind-app 
was to increase the accessibility of the program to brain 
tumor patients in a cost-efficient mode of delivery, while 
maintaining the contents of the original program. Before we 
initiated an RCT to evaluate the efficacy of ReMind, we con-
ducted a small-scale study to investigate the feasibility of, 
and potential barriers to, the use of the program in the clini-
cal (research) setting in terms of accrual, attrition, adherence 
and patient satisfaction. Since cognitive telerehabilitation 
has not yet been investigated in adult patients with primary 
brain tumors (i.e. vulnerable patients with higher levels of 
fatigue, psychological distress and concentration problems), 
this feasibility study is an important first step.
Methods
Participants
Patients with a radiologically suspected supratentorial 
low-grade glioma or meningioma, who were scheduled for 
resective surgery in the Elisabeth-TweeSteden Hospital Til-
burg, were invited to participate. Patients who met any of 
the following criteria were excluded: history of intracranial 
neurosurgery, history of severe psychiatric or neurological 
disorder, diagnosis of multiple meningioma, complete unfa-
miliarity with the use of computers, lack of basic proficiency 
in Dutch, inability to undergo neuropsychological assess-
ment due to motor/language/visual problems, Karnofsky 
performance score (KPS) below 70 or a premorbid IQ below 
85. Patients who were referred to in- or outpatient cognitive 
rehabilitation were excluded as well. The projected sample 
size was 15. Informed consent was obtained from all indi-
vidual participants included in the study.
Design and procedure
This single-arm pilot study was approved by the local medi-
cal ethical review board (METC Brabant: NL51152.028.14), 
registered in The Netherlands National Trial Register (NTR 
5392).
Two weeks before surgery, patients were informed about 
the study by a nurse practitioner. Interested patients received 
an information letter. One day before surgery, patients were 
hospitalized and neuropsychological assessment (T0) was 
carried out as part of usual clinical care. At the beginning 
of the assessment, patients who were willing to participate 
in the study provided written informed consent. If patients 
chose to make use of the possibility to involve a significant 
other in the cognitive rehabilitation trajectory (see below), 
the significant other had to give informed consent as well. 
Three months after surgery, a second usual care neuropsy-
chological assessment (T3) was conducted. Immediately 
afterwards, the cognitive telerehabilitation program ReMind 
commenced. Three months later (i.e. 6 months after sur-
gery), after completing ReMind, the final neuropsychologi-
cal assessment took place (T6) for the purpose of this study. 
Additionally, study-specific evaluation questionnaires were 
completed. The current study was embedded in standard 
clinical care provided by the hospital.
Intervention
The program
The cognitive telerehabilitation program Remind was devel-
oped in a joint patient/researcher initiative and is based on 
our previously evaluated face-to-face cognitive rehabilitation 
program [9, 12, 20]. The ReMind-app is provided via an iPad 
(Fig. 1a) and is available in both Dutch and English. In the 
current study, the Dutch version was used.
Similar to the original program [12], ReMind consists 
of compensation training, including psychoeducation and 
teaching of compensatory skills, and attention retraining (see 
Fig. 1b, c). In the compensation training, psychoeducation 
about cognitive functions is provided in six modules, namely 
on (1) Cognitive functions, (2) Influences, (3) Compensa-
tion, (4) Attention, (5) Planning & control, and (6) Memory. 
Additionally, in each module, compensatory strategies are 
taught and many exercises are included to learn to apply 
these strategies in everyday life. Patients learn, for example, 
to minimize distraction and deal with time pressure, and to 
optimally use external devices for support. Due to the strong 
interdependence of all cognitive functions, the strategy train-
ing was designed so that patients should go through all the 
six modules one by one, to benefit the most from the strat-
egy training. Progression through each module is visualized, 
with checkmarks at the bottom of the screen (Fig. 1b).
In the retraining part, named C-Car, four different modes 
of attention are trained, namely sustained, selective, alter-
nating and divided attention. It includes visual and audi-
tory exercises, wherein both verbal and numeric stimuli are 
presented. All patients started with the same version of this 
training, independently of their pre-intervention neuropsy-
chological scores. Series of hierarchically graded tasks were 
used, so that higher levels are reached, if previous levels 
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are mastered. In this manner, the retraining is tailored to 
the level of the patient. After each exercise, patients receive 
feedback on their performance.
During the development of the app, optimum use was 
made of the additional (technical) possibilities the new 
environment offered. The instructional texts of the strategy 
training are provided in videos, audio clips and read-only 
formats and patients can look back as often as they feel nec-
essary. ReMind incorporates several other functions to make 
it as user-friendly as possible, such as help-overlay screens 
and links to explanations of important definitions. The pro-
gram also offers the possibility to involve a significant other, 
which can be a spouse, family member, friend or profes-
sional: the ReMinder. Patients can send this ReMinder an 
email from anywhere in the program, for example to ask for 
advice when they get stuck in a text or an exercise.
Guidance
Three months after surgery, immediately after the sec-
ond neuropsychological assessment (T3), a face-to-face 
appointment was planned, to hand over the iPad on which 
the ReMind-app was installed together with an explanation 
of the app. During the intervention period, the researcher 
contacted the patients by telephone every 2 weeks, to check 
on their progress, plan the course of their training and to 
address questions. It was advised and expected that patients 
spent 3 h per week on the program, to complete the program 
within 10 weeks. A second face-to-face appointment took 
place at the end of the program, to retrieve the iPad and to 
collect the completed questionnaires.
Measures
Accrual and attrition
Accrual was defined as the total number of included patients 
as compared to the number of invited patients. The num-
ber of patients who declined participation and reasons for 
decline were carefully recorded. The same was done for 
the number of patients who dropped out of the study and 
reason(s) for this attrition.
Adherence
Adherence to the program was indicated by both the num-
ber of completed module sections in the strategy training 
and the number of exercises performed in the retraining, 
each expressed in percentages of total available sections 
and exercises, respectively. If patients completed ≥ 80% of 
both the strategy training and the retraining, adherence was 
considered acceptable. To calculate mean percentages for 
the group, a maximum of 100% per individual was used, 
even if patients worked through the program more than once. 
Reasons for non-adherence as reported in the telephone calls 
during the intervention and in the face-to-face appointment 
at the end of the program were recorded.
Fig. 1  Screenshots of different parts of ReMind: a homepage, b strat-
egy training, and c retraining
 Journal of Neuro-Oncology
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Patient experience
After completing the program, patients were requested to fill 
out a study-specific questionnaire, evaluating their experi-
ences with ReMind (e.g., satisfaction, enjoyment, usefulness 
and burden), whether they would recommend any changes 
in (elements of) the program, and if they would recommend 
it to other patients.
Feasibility of neuropsychological assessments
Neuropsychological tests and patient-reported outcome 
measures (PROMs) were administered to describe baseline 
functioning of the patients and to test the feasibility of pro-
cedures for later use on a larger scale. Objective cognitive 
functioning was assessed by the computerized neuropsy-
chological test battery CNS Vital Signs [21, 22] and three 
paper-and-pencil tests, namely Letter Fluency, Digit Span 
(WAIS), and Paired Associates (WMS) [23–25]. Z-scores 
were calculated using normative data and Z-scores ≤ − 1.5 
were considered as low. Subjective cognitive functioning 
was assessed with the Cognitive Failures Questionnaire 
(CFQ) [26]. Based on Dutch representative normative data 
[27], a total score of ≥ 42 was considered as clinically high. 
Symptoms of anxiety and depression were assessed with the 
Hospital Anxiety and Depression Scale (HADS) [28, 29], 
with a cut-off for both scales of ≥ 8.
Data analysis
Percentages of eligible, included, excluded and dropped-out 
patients were calculated. Descriptive statistics of partici-
pants are presented. This feasibility study (n = 15) was not 




Data on accrual and attrition are presented in a flow diagram 
(Fig. 2). Out of 65 consecutive patients who were scheduled 
to undergo surgery for presumed low-grade glioma/menin-
gioma, 37 patients (57%) were excluded. Of the 28 eligible 
patients who were invited to participate, 15 patients provided 
informed consent (54%) and 13 patients (46%) declined. The 
most important reason for decline was that patients (n = 7) 
did not experience cognitive deficits and felt no need to fol-
low a cognitive rehabilitation program at this stage.
In the 3 months prior to the start of the intervention, one 
patient withdrew from the study because of lack of cogni-
tive complaints. An additional patient was excluded after 
informed consent, since she was referred to cognitive reha-
bilitation elsewhere. No dropout occurred during the inter-
vention phase. Nine participants (69%) chose to involve a 
significant other (in all cases, a spouse).
Demographic, clinical and neuropsychological 
characteristics
Table 1 shows the demographic, clinical and neuropsycho-
logical characteristics of the sample. Thirteen patients (38% 
female), with a mean age of 52 years (range 40–68), fol-
lowed the cognitive rehabilitation program and completed 
all assessments. Six patients were diagnosed with a grade I 
meningioma, one patient with a WHO grade II meningioma 
and four patients with a WHO grade II glioma. For two other 
patients, the radiologically suspected diagnosis of low-grade 
glioma was not confirmed after surgery (Table 1). After 
surgery, five patients (38%) were treated with radiotherapy 
and three of these patients also received chemotherapy at 
T3. The majority (69%) of the patients were highly edu-
cated. Before the start of the intervention, seven patients 
demonstrated low Z-scores (≤ − 1.5) on one or more meas-
ures of objective cognitive functioning. Based on the scores 
of the HADS, three of the patients possibly suffered from 
depression, and one of them possibly from anxiety as well 
(Table 1).
Adherence
Adherence per participant is presented in Table 1. On aver-
age, participants completed 71% of the strategy training 
76% of the retraining. According to our definition of adher-
ence (completion of ≥ 80% of both the strategy training and 
the retraining), seven out of 13 patients (54%) adhered to 
the program. Six patients (46%) completed the entire strat-
egy training and seven patients (54%) completed the entire 
retraining. Four patients (31%) fully completed both the 
strategy- and retraining. Three participants reported specific 
circumstances that explained non-adherence: one was con-
fronted with serious illness of her spouse, one experienced 
technical problems with the retraining part of the program 
(which were solved afterwards) and one moved to a new 
house during the intervention. Two participants who had a 
(very) low adherence to the program reported that they were 
too busy with other activities and had other priorities. On 
the other hand, other patients also experienced interfering 
circumstances, but were still able to adhere to the interven-
tion. One low-grade glioma patient reported that following 
the program was burdensome in combination with adjuvant 
tumor treatment.
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Patient experience
Results of the study-specific evaluation questionnaire are 
listed in Table 2. The majority evaluated the difficulty and 
the quantity of psychoeducation, fill-in exercises (to practice 
with learned strategies) and retraining tasks as sufficient. 
However, four participants reported that there were too many 
fill-in exercises included in the strategy training, whereas 
four other participants rated the retraining as (a bit too) easy 
and found there were (too) few retraining exercises included 
in the program. Furthermore, eight patients enjoyed working 
with ReMind. Using an iPad-app for cognitive rehabilita-
tion was appreciated. Overall, 11 patients (85%) evaluated 
the cognitive rehabilitation program ReMind as “good” or 
“excellent”. All participants indicated that they would rec-
ommend the program to other brain tumor patients.
Feasibility of neuropsychological assessments
Three patients were excluded from the study beforehand, 
because they did not undergo the first neuropsychological 
assessment (T0) due to (logistical) problems with plan-
ning. All 13 participants fully completed neuropsychologi-
cal assessments, one questionnaire of a participant was not 
returned.
Discussion
ReMind is the first cognitive telerehabilitation program 
specifically developed for adult patients with primary brain 
tumors. The current pilot study was designed to test the fea-
sibility of an evidence-based telerehabilitation program in 
65 presumed LGG/MEN patients
scheduled for surgery
Excluded:n = 37 (57%)
• History of neurological or psychiatric disorder (11)
• Previous intracranial surgery (6)
• KPS < 70 (6)
• Multiple meningiomas (3)
• Lack of basic proficiency in Dutch (3)
• Unfamiliarity with computers (2)
• Visual impairment (2)
• IQ < 85 (1)
• Logistic/scheduling problems (3)
Invitation to participate
n = 28 (43%)
NPA T0
n = 15 (54%)
Declined: n = 13 (46%)
• No cognitive complaints/no need for cognitive
rehabilitation (7)
• No affinity with iPad (2)
• Other priorities (2)
• Wanted to move on with normal life after surgery 
(1)
• Visual problems (not able to read/use a screen for
too long) (1)
NPA T3
n = 13 (86%)
Excluded:n = 1 (7%)
• Cognitive rehabilitation elsewhere
Attrition: n = 1 (7%)




Fig. 2  Flowchart of enrolment and attrition. NPA neuropsychological assessment, LGG low-grade glioma, MEN meningioma, KPS Karnofsky 
performance score
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the clinical (research) setting in preparation for a larger RCT. 
The results suggest that, for the subset of interested patients 
who were included in the study based on specific criteria, 
cognitive rehabilitation by using the ReMind-app was fea-
sible. Overall, participants were satisfied with the program 
and dropout was low.
The recruitment of participants to the study was the most 
challenging aspect of this feasibility study. A substantial part 
(57%) of the patients who were undergoing surgery for low-
grade glioma or meningioma were not eligible based on the 
exclusion criteria. In hindsight, the exclusion criteria appeared 
to be overly strict, which, in an attempt to reduce bias through 
controlling patients’ characteristics and potential confounders, 
potentially compromised the generalizability of the results to 
the target patient population of patients with presumed low-
grade glioma and meningioma [30, 31]. In particular, a large 
proportion of patients with a history of neurological/psychi-
atric disorders or previous intracranial surgery were excluded, 
although cognitive rehabilitation may be relevant for them as 
well. Based on these experiences, we adapted the inclusion 
criteria of the RCT. Furthermore, 46% of eligible patients 
declined participation, half of them reporting to feel no need 
to undergo cognitive rehabilitation at this stage (n = 7). Two 
patients specifically declined participation since an iPad-based 
intervention was not appealing to them.
With respect to adherence, 54% of the participants met 
the criterion for sufficient (completion of ≥ 80% of both the 
strategy training and the retraining) adherence, which was 
comparable with other studies that investigated psychologi-
cal eHealth interventions in other patient populations [32], 
but not as high as the adherence to the face-to-face program 
in our previous RCT [9, 12]. Whereas our previous study 
Table 2  Post-intervention ratings of different aspects of ReMind (n = 13)
a No change, there was no impact on daily life (5) or no change, impact remained the same (2)
b Coping is still good (8), or coping is still not good (0)
Difficulty of (Too) easy Just right (Too) difficult
 Information in strategy training 3 10 –
 Fill-in exercises in strategy training 1 10 2
 Retraining (C-Car game) 4 9 –
Amount/number of (Too) little/few About right (Too) much/many
 Information in strategy training 1 12 –
 Fill-in exercises in strategy training – 9 4
 Retraining exercises (C-Car game) 4 8 1
 Supervision of the researcher/trainer – 13 –
Usefulness of (Very) useful Neutral Not useful
 Information in strategy training 7 6 –
 Fill-in exercises in strategy training 3 9 1
 Retraining exercises (C-Car game) 11 2 –
 (Telephone) contact with the researcher/trainer 13 – –
Content addressed daily problems Fully/largely Partly Not
8 4 1
Application of learnt (strategies) in daily life Often/regularly Sometimes Seldom/never
3 5 5
Impact of cognitive problems has changed Yes, positively Noa Yes, negatively
6 7 –
Coping with cognitive problems has changed Improved coping Nob Worsened coping
5 8 –
Pleasantness of working on ReMind (Very) pleasant Neutral (Very) unpleasant
8 3 2
Excellent/good Sufficient Insufficient/poor
Using an iPad-app for cognitive rehabilitation 11 1 1
Capability of the researcher/trainer 13 – –
Contact with the researcher/trainer 12 1 –
Overall rating of the program 11 1 1
Yes No
Recommendation to other brain tumor patients 13 0
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included a sample of patients with clinically stable lower-
grade gliomas with a disease duration of several years, the 
patients in the present study participated only shortly after, 
or even during, the tumor treatment phase of their disease. 
For example, five patients received adjuvant treatment dur-
ing the intervention. The patients in our pilot study lived 
through a turbulent period, in which psychosocial devel-
opments, in addition to medical treatment and recovery, 
are predominating. Some of them resume their work and/
or family care during this period. It may be that, for some 
patients, undergoing cognitive rehabilitation in this phase is 
(too) burdensome. Furthermore, in contrast to our previous 
study, experiencing subjective cognitive (or objective) dys-
function was not an inclusion criterion. Consequently, not 
all patients in our sample experienced cognitive dysfunction 
(yet), which may have led to a lack of motivation to fully 
adhere to the program for some. Along this line, all three 
participants who reported psychological complaints showed 
(more than) sufficient adherence rates.
In order to reduce the well-known problems with adher-
ence in remote interventions and, in particular, to find substi-
tutes for the low amount of (face-to-face) supervision, before 
the start of the pilot study, we incorporated several features 
into the program that are known to enhance adherence 
[32–34]. For example, we provided regular guidance during 
the intervention, through telephone counseling and by provi-
sion of feedback from the program itself. Additionally, the 
program offers the possibility to patients to involve a signifi-
cant other in the process, an option that nine patients chose. 
Seven of these patients showed sufficient adherence rates. 
Despite the efforts made, adherence rates were suboptimal.
Overall, participants who followed the program reported 
that an iPad-app was an appropriate mode of delivery of 
cognitive rehabilitation. In fact, this mode enables many 
patients with brain tumors to follow a cognitive rehabilita-
tion program at their own homes, which is a great advantage 
since many patients are not allowed to drive due to epileptic 
seizures. Another important advantage is that patients can 
follow the program at their own pace and can spread the 
material over as many sessions as they want, which could 
be helpful for (vulnerable and/or) older patients in particu-
lar [20]. All patients indicated that they would recommend 
to program to other brain tumor patients. However, some 
participants indicated that the retraining was too easy for 
them. Therefore, we decided to expand the retraining with 
nine more difficult exercises for use in the RCT and beyond, 
ensuring that the retraining remains challenging for each 
individual.
In intervention studies, the timing of the intervention is 
an important, but difficult issue, wherein a balance is sought 
between intervening not too early, but also not too late. 
Research in patients with brain tumors demonstrated that the 
need for supportive care is very high, especially in the early 
stage of the disease [14]. We hypothesized that early cogni-
tive rehabilitation may enhance the recovery process and may 
prevent/minimize the negative impact of cognitive side effects 
of adjuvant treatment, and we decided to start the interven-
tion soon after physical recovery from the surgery and after 
completion of radiotherapy. At three months after surgery, the 
intervention could be easily embedded in the existing logistics 
of our clinical aftercare, thereby minimizing patient burden. 
Because of the hypothesized preventative effects at this stage, 
both patients with and without cognitive complaints/deficits 
were eligible. We assume that several aspects of our cognitive 
rehabilitation program, for example psychoeducation about 
cognitive (dys)functioning in patients with brain tumors, could 
be helpful for a broad group of patients at an early stage.
We have started a larger trial to evaluate the efficacy of 
ReMind with respect to cognitive functioning and patient-
reported outcomes, in which patients are consecutively rand-
omized to an intervention group or waiting-list control group 
by minimization [35] after the 3 months’ assessment. Based 
on the experiences in the pilot study, exclusion criteria were 
revised to include a broader group of patients and two par-
ticipating medical centers were added. A 6-month follow-
up assessment was added to the design and participants are 
requested to keep records of their time spent on the program 
using registration forms. In addition, a pilot study in 20 gli-
oma patients with stable disease and cognitive complaints is 
currently being conducted, using the English version of the 
ReMind-app, at the University of California, San Francisco 
(UCSF) (clinicaltrials.gov NCT02783495). Ultimately, if the 
results of the RCT demonstrate beneficial effects of ReMind 
at the postoperative stage, this telerehabilitation program may 
enable many patients with brain tumors to follow a cognitive 
rehabilitation program at their own pace in their own environ-
ment early in the course of the disease.
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